DK1520039T3 - Mitokondrisk polymorfi, forbundet til en prædisposition til udvikling af uhensigtsmæssig ardannelse og fibrose - Google Patents
Mitokondrisk polymorfi, forbundet til en prædisposition til udvikling af uhensigtsmæssig ardannelse og fibroseInfo
- Publication number
- DK1520039T3 DK1520039T3 DK03718946T DK03718946T DK1520039T3 DK 1520039 T3 DK1520039 T3 DK 1520039T3 DK 03718946 T DK03718946 T DK 03718946T DK 03718946 T DK03718946 T DK 03718946T DK 1520039 T3 DK1520039 T3 DK 1520039T3
- Authority
- DK
- Denmark
- Prior art keywords
- predisposition
- development
- fibrosis
- linked
- mitochondrial
- Prior art date
Links
- 230000002438 mitochondrial effect Effects 0.000 title abstract 3
- 206010016654 Fibrosis Diseases 0.000 title abstract 2
- 230000004761 fibrosis Effects 0.000 title abstract 2
- 230000037390 scarring Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 101150087323 COI gene Proteins 0.000 abstract 1
- 102100025287 Cytochrome b Human genes 0.000 abstract 1
- 108010075028 Cytochromes b Proteins 0.000 abstract 1
- 102000015782 Electron Transport Complex III Human genes 0.000 abstract 1
- 108010024882 Electron Transport Complex III Proteins 0.000 abstract 1
- 206010071602 Genetic polymorphism Diseases 0.000 abstract 1
- 101150102231 ND2 gene Proteins 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000035772 mutation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- External Artificial Organs (AREA)
- Saccharide Compounds (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0209812.7A GB0209812D0 (en) | 2002-04-30 | 2002-04-30 | Genetic testing |
| PCT/GB2003/001717 WO2003093506A2 (en) | 2002-04-30 | 2003-04-23 | Mitochondrial polymorphisms linked to a predisposition for the development of inappropriate scarring or fibrosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1520039T3 true DK1520039T3 (da) | 2008-11-17 |
Family
ID=9935744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03718946T DK1520039T3 (da) | 2002-04-30 | 2003-04-23 | Mitokondrisk polymorfi, forbundet til en prædisposition til udvikling af uhensigtsmæssig ardannelse og fibrose |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050239071A1 (da) |
| EP (1) | EP1520039B1 (da) |
| JP (1) | JP4384025B2 (da) |
| AT (1) | ATE404696T1 (da) |
| AU (1) | AU2003222980B2 (da) |
| CA (1) | CA2482812A1 (da) |
| DE (1) | DE60322901D1 (da) |
| DK (1) | DK1520039T3 (da) |
| ES (1) | ES2310239T3 (da) |
| GB (1) | GB0209812D0 (da) |
| WO (1) | WO2003093506A2 (da) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9928508B2 (en) | 2000-08-04 | 2018-03-27 | Intellectual Ventures I Llc | Single sign-on for access to a central data repository |
| US7666588B2 (en) | 2001-03-02 | 2010-02-23 | Ibis Biosciences, Inc. | Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy |
| US7226739B2 (en) | 2001-03-02 | 2007-06-05 | Isis Pharmaceuticals, Inc | Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations |
| US20030027135A1 (en) | 2001-03-02 | 2003-02-06 | Ecker David J. | Method for rapid detection and identification of bioagents |
| US20040121311A1 (en) | 2002-12-06 | 2004-06-24 | Ecker David J. | Methods for rapid detection and identification of bioagents in livestock |
| US7217510B2 (en) | 2001-06-26 | 2007-05-15 | Isis Pharmaceuticals, Inc. | Methods for providing bacterial bioagent characterizing information |
| CA2508726A1 (en) | 2002-12-06 | 2004-07-22 | Isis Pharmaceuticals, Inc. | Methods for rapid identification of pathogens in humans and animals |
| US8057993B2 (en) | 2003-04-26 | 2011-11-15 | Ibis Biosciences, Inc. | Methods for identification of coronaviruses |
| US7964343B2 (en) | 2003-05-13 | 2011-06-21 | Ibis Biosciences, Inc. | Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| US8158354B2 (en) | 2003-05-13 | 2012-04-17 | Ibis Biosciences, Inc. | Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| US8546082B2 (en) | 2003-09-11 | 2013-10-01 | Ibis Biosciences, Inc. | Methods for identification of sepsis-causing bacteria |
| US8097416B2 (en) | 2003-09-11 | 2012-01-17 | Ibis Biosciences, Inc. | Methods for identification of sepsis-causing bacteria |
| US8288523B2 (en) | 2003-09-11 | 2012-10-16 | Ibis Biosciences, Inc. | Compositions for use in identification of bacteria |
| US8163895B2 (en) | 2003-12-05 | 2012-04-24 | Ibis Biosciences, Inc. | Compositions for use in identification of orthopoxviruses |
| US7666592B2 (en) | 2004-02-18 | 2010-02-23 | Ibis Biosciences, Inc. | Methods for concurrent identification and quantification of an unknown bioagent |
| JP5236286B2 (ja) * | 2004-05-07 | 2013-07-17 | セレラ コーポレーション | 肝線維症に関連する遺伝的多型、その検出方法および使用 |
| WO2005117270A2 (en) | 2004-05-24 | 2005-12-08 | Isis Pharmaceuticals, Inc. | Mass spectrometry with selective ion filtration by digital thresholding |
| US20050266411A1 (en) | 2004-05-25 | 2005-12-01 | Hofstadler Steven A | Methods for rapid forensic analysis of mitochondrial DNA |
| US7811753B2 (en) | 2004-07-14 | 2010-10-12 | Ibis Biosciences, Inc. | Methods for repairing degraded DNA |
| US8182992B2 (en) | 2005-03-03 | 2012-05-22 | Ibis Biosciences, Inc. | Compositions for use in identification of adventitious viruses |
| US8084207B2 (en) | 2005-03-03 | 2011-12-27 | Ibis Bioscience, Inc. | Compositions for use in identification of papillomavirus |
| EP1904655A2 (en) | 2005-07-21 | 2008-04-02 | Isis Pharmaceuticals, Inc. | Methods for rapid identification and quantitation of nucleic acid variants |
| WO2007118222A2 (en) | 2006-04-06 | 2007-10-18 | Ibis Biosciences, INC | Compositions for the use in identification of fungi |
| CA2663029C (en) | 2006-09-14 | 2016-07-19 | Ibis Biosciences, Inc. | Targeted whole genome amplification method for identification of pathogens |
| US8871471B2 (en) | 2007-02-23 | 2014-10-28 | Ibis Biosciences, Inc. | Methods for rapid forensic DNA analysis |
| WO2008151023A2 (en) | 2007-06-01 | 2008-12-11 | Ibis Biosciences, Inc. | Methods and compositions for multiple displacement amplification of nucleic acids |
| EP2349549B1 (en) | 2008-09-16 | 2012-07-18 | Ibis Biosciences, Inc. | Mixing cartridges, mixing stations, and related kits, and system |
| EP2347254A2 (en) | 2008-09-16 | 2011-07-27 | Ibis Biosciences, Inc. | Sample processing units, systems, and related methods |
| US8534447B2 (en) | 2008-09-16 | 2013-09-17 | Ibis Biosciences, Inc. | Microplate handling systems and related computer program products and methods |
| EP2396803A4 (en) | 2009-02-12 | 2016-10-26 | Ibis Biosciences Inc | IONIZATION PROBE ASSEMBLIES |
| WO2010104798A1 (en) | 2009-03-08 | 2010-09-16 | Ibis Biosciences, Inc. | Bioagent detection methods |
| WO2010114842A1 (en) | 2009-03-30 | 2010-10-07 | Ibis Biosciences, Inc. | Bioagent detection systems, devices, and methods |
| WO2011008972A1 (en) | 2009-07-17 | 2011-01-20 | Ibis Biosciences, Inc. | Systems for bioagent identification |
| WO2011008971A1 (en) | 2009-07-17 | 2011-01-20 | Ibis Biosciences, Inc. | Lift and mount apparatus |
| US9416409B2 (en) | 2009-07-31 | 2016-08-16 | Ibis Biosciences, Inc. | Capture primers and capture sequence linked solid supports for molecular diagnostic tests |
| WO2011017656A2 (en) | 2009-08-06 | 2011-02-10 | Ibis Biosciences, Inc. | Non-mass determined base compositions for nucleic acid detection |
| EP3225695A1 (en) | 2009-10-15 | 2017-10-04 | Ibis Biosciences, Inc. | Multiple displacement amplification |
| US9758840B2 (en) | 2010-03-14 | 2017-09-12 | Ibis Biosciences, Inc. | Parasite detection via endosymbiont detection |
| FI20100211A0 (fi) * | 2010-05-19 | 2010-05-19 | Mas Metabolic Analytical Servi | Menetelmä ateroskleroosialttiuden geneettiseksi diagnosoimiseksi |
| CN103981255B (zh) * | 2014-04-01 | 2016-06-01 | 重庆医科大学附属儿童医院 | 一种Leber遗传性视神经病变体外诊断试剂盒 |
| KR101651817B1 (ko) * | 2015-10-28 | 2016-08-29 | 대한민국 | Ngs 라이브러리 제작용 프라이머 세트 및 이를 이용한 ngs 라이브러리 제작방법 및 키트 |
| KR102026138B1 (ko) * | 2017-08-02 | 2019-09-27 | 충남대학교산학협력단 | Crif1 억제제를 함유하는 켈로이드 및 비후성 반흔 형성 억제 또는 치료용 조성물 |
| CN110221011A (zh) * | 2019-05-22 | 2019-09-10 | 南京鼓楼医院 | 系统性硬化症诊断的脂肪酸代谢物分析检测方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4273869A (en) * | 1979-04-16 | 1981-06-16 | The Regents Of The University Of Minnesota | Cystic fibrosis detection method |
| SU1731489A1 (ru) * | 1986-09-25 | 1992-05-07 | Институт электроники им.У.А.Арифова | Устройство дл электроэрозионной прошивки отверстий |
-
2002
- 2002-04-30 GB GBGB0209812.7A patent/GB0209812D0/en not_active Ceased
-
2003
- 2003-04-23 DE DE60322901T patent/DE60322901D1/de not_active Expired - Lifetime
- 2003-04-23 JP JP2004501642A patent/JP4384025B2/ja not_active Expired - Lifetime
- 2003-04-23 DK DK03718946T patent/DK1520039T3/da active
- 2003-04-23 CA CA002482812A patent/CA2482812A1/en not_active Abandoned
- 2003-04-23 AU AU2003222980A patent/AU2003222980B2/en not_active Ceased
- 2003-04-23 ES ES03718946T patent/ES2310239T3/es not_active Expired - Lifetime
- 2003-04-23 EP EP03718946A patent/EP1520039B1/en not_active Expired - Lifetime
- 2003-04-23 AT AT03718946T patent/ATE404696T1/de not_active IP Right Cessation
- 2003-04-23 US US10/512,454 patent/US20050239071A1/en not_active Abandoned
- 2003-04-23 WO PCT/GB2003/001717 patent/WO2003093506A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE60322901D1 (de) | 2008-09-25 |
| AU2003222980A1 (en) | 2003-11-17 |
| AU2003222980B2 (en) | 2008-03-06 |
| WO2003093506A2 (en) | 2003-11-13 |
| JP2005529592A (ja) | 2005-10-06 |
| EP1520039B1 (en) | 2008-08-13 |
| HK1070109A1 (en) | 2005-06-10 |
| GB0209812D0 (en) | 2002-06-05 |
| EP1520039A2 (en) | 2005-04-06 |
| ATE404696T1 (de) | 2008-08-15 |
| ES2310239T3 (es) | 2009-01-01 |
| WO2003093506A3 (en) | 2004-03-11 |
| CA2482812A1 (en) | 2003-11-13 |
| JP4384025B2 (ja) | 2009-12-16 |
| US20050239071A1 (en) | 2005-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1520039T3 (da) | Mitokondrisk polymorfi, forbundet til en prædisposition til udvikling af uhensigtsmæssig ardannelse og fibrose | |
| Ladd-Acosta et al. | The role of epigenetics in genetic and environmental epidemiology | |
| Bonnefond et al. | Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity through one-step PCR-based enrichment in combination with next-generation sequencing | |
| FI20050011A7 (fi) | Menetelmä ja testipakkaus tyypin 2 diabetes mellituksen riskin havaitsemiseksi | |
| WO2007147073A3 (en) | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats | |
| MY169852A (en) | Detection of genetic or molecular aberrations associated with cancer | |
| Jeremias et al. | Prospects for incorporation of epigenetic biomarkers in human health and environmental risk assessment of chemicals | |
| Brancato et al. | 8-Oxo-7, 8-dihydro-2′-deoxyguanosine and other lesions along the coding strand of the exon 5 of the tumour suppressor gene P53 in a breast cancer case-control study | |
| WO2001088189A3 (en) | Microsatellite-aflp® | |
| Aavikko et al. | WNT2 activation through proximal germline deletion predisposes to small intestinal neuroendocrine tumors and intestinal adenocarcinomas | |
| ATE446385T1 (de) | Polymorphismen im nod2/card15 gen | |
| Cunningham et al. | Performance of amplified DNA in an Illumina GoldenGate BeadArray assay | |
| Margalit et al. | Long-read structural and epigenetic profiling of a kidney tumor-matched sample with nanopore sequencing and optical genome mapping | |
| DE602005020592D1 (de) | Cpg-amplicon und array-protokoll | |
| WO2004113574A3 (en) | Methods for disease screening | |
| CA2575405A1 (en) | Method for diagnosing liver fibrosis | |
| WO2007056332A3 (en) | Molecular diagnosis of autoimmune diseases | |
| Sadler et al. | Characterization of copy-number variants in a large cohort of patients with von Willebrand disease reveals a relationship between disrupted regions and disease type | |
| Giraudeau et al. | Characterization of common genetic variants in cathepsin K and testing for association with bone mineral density in a large cohort of perimenopausal women from Scotland | |
| Mune et al. | HSD11B2 CA-repeat and sodium balance | |
| AU2003233292A1 (en) | Protein c polymorphisms | |
| EP1529849A3 (en) | Reliable method for assessing and reporting the risks of disease, contamination and losses caused by one or more microorganisms in a matrix or environment | |
| Bouras et al. | Splicing analysis of 24 potential spliceogenic variants in MMR genes and clinical interpretation based on refined ACMG/AMP criteria | |
| EP1260817A3 (en) | Method for direct measurement of coagulation factor VIIa activity in plasma | |
| ATE464553T1 (de) | Verfahren zur herzerkrankungsbewertung in einer einzelperson |